Abbott Labs: Q1 above estimates
(CercleFinance.com) - Published on Wednesday before Wall Street opened, Abbott Laboratories' Q1 results included EPS of 23 cents, down one cent relative to Q1 2017.
However, adjusted EPS reached 59 cents, up 11 cents, one cent above the consensus of 58 cents.
Revenue reached 7.39 billion dollars, up sharply from the 6.34 billion dollars in Q1 2017. Analysts forecast revenue of 7.29 billion dollars.
Abbott Laboratories currently targets adjusted EPS of between 70 cents and 72 cents.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
However, adjusted EPS reached 59 cents, up 11 cents, one cent above the consensus of 58 cents.
Revenue reached 7.39 billion dollars, up sharply from the 6.34 billion dollars in Q1 2017. Analysts forecast revenue of 7.29 billion dollars.
Abbott Laboratories currently targets adjusted EPS of between 70 cents and 72 cents.
Copyright (c) 2018 CercleFinance.com. All rights reserved.